American College of Veterinary Internal Medicine (ACVIM)’s Post

November is #NationalPetCancerAwarenessMonth, and we’re celebrating the crucial role that veterinary oncologists play in treating pets with unique or aggressive cancers. When seven-year-old Lily was first diagnosed with squamous cell carcinoma, her prognosis was uncertain. Thanks to innovative treatment options like electrochemotherapy and the dedicated care of Carrie Wood, DVM, DACVIM (Oncology) at Cummings School of Veterinary Medicine at Tufts University, Lily's tumor has been significantly reduced, bringing her a better quality of life. ➡️ Read the full story and discover how veterinary oncologists are revolutionizing cancer care: https://buff.ly/4fjpsen

🐾 Building on science developed by the Purdue Institute for Cancer Research and the Purdue University College of Veterinary Medicine & Veterinary Hospital, Purdue University has launched a cutting-edge trial with Akston Biosciences to co-develop an immunotherapy to treat #cancer in dogs. The study has the potential to help advance cancer solutions in humans, too. Read more: http://purdue.link/k9.bcct #Cancer | #VetMed | #CancerResearch | #Research | #dogs | #Oncology | #Purdue | #PurdueVetMed | #Science

Purdue University and the Purdue University College of Veterinary Medicine & Veterinary Hospital, in partnership with Akston Biosciences Corporation, has initiated the enrollment of dogs with urinary bladder cancer in a clinical trial of a pioneering immunotherapy, designed to target and block a specific protein on cancer cells. This groundbreaking technology was developed at the College of Veterinary Medicine and the Purdue Institute for Cancer Research (PICR). This study will assess safety and efficacy within dogs suffering from urinary blader cancer, with potential applications for human treatments. #research #cancer #healthcare #clinicaltrial #purdue #indiana #lifesciences

“In veterinary medicine, many of our opinions are shaped by retrospective studies and anecdotes. We tend to forget this as we study for our board exams.” Dr. Chand Khanna, president of Ethos Discovery, shares insights on preventing misinformed euthanasia for splenic tumor rupture in dogs and recent findings that challenge historic misconceptions. Learn more about this school of thought here: https://lnkd.in/evw6qbyB #VetMed #Podcast #DogHealth #Cancer #Hemangiosarcoma #Mentorship #Research #ClinicalTrials

Detecting Canine Cancer with Rapid Raman Molecular Urinalysis A study published in Frontiers in Veterinary Science in February, led by researchers from Virginia Tech has developed a new method to detect cancer in dogs using rapid Raman molecular urinalysis: https://lnkd.in/eZc7734m This noninvasive technique analyzes urine samples to create a unique spectral fingerprint, which allows for remarkable accuracy in detecting various cancers. The urine screening test achieved a 92.7% overall accuracy in distinguishing between cancerous and non-cancerous samples. The test demonstrated 94.0% sensitivity and 90.5% specificity, highlighting its reliability. The method was effective in detecting lymphoma, urothelial carcinoma, osteosarcoma, and mast cell tumors. Unlike traditional biopsies, this technique uses urine samples, making it simpler and less stressful for dogs. Cancer is common in dogs, with nearly 1 in 4 developing some form of neoplasia during their lifetime. Early detection is crucial for effective treatment and better outcomes. This innovative approach offers a rapid, accurate, and non-invasive way to screen for cancer, potentially revolutionizing how veterinarians diagnose and manage cancer in dogs. Take a look at Virgina Tech’s Animal Care and Research Center: https://lnkd.in/eevZNtS8 #CanineHealth #DogCancerDetection #VeterinaryMedicine #JoyfulDog #VirginiaDogTrainer #DogTrainer #TimetoTrain

November is Pet Cancer Awareness Month! 🩺 By adopting advanced diagnostic techniques like MRI, CT scans, cytology, histopathology, and molecular testing, more lives could be saved. Have you used any of these methods? Share your experiences below, and let’s inspire progress in veterinary oncology! #VetandTech #PetCancerAwareness #VeterinaryOncology #PetHealth #SavingLives

Research into cats’ chronic kidney disease may take a giant leap forward thanks to the development of the first ever high-quality feline induced pluripotent stem cells (iPSCs).   For the first time in the world, researchers at the Osaka Metropolitan University have generated high-quality feline footprint- and feeder-free iPSCs. The researchers utilized six transcription factors via the Sendai virus vector to generate the iPSCs from cat cells. They expect the cells will be used around the world in veterinary regenerative medicine research and to elucidate the pathogenesis of diseases, like cats’ chronic kidney disease and diabetes. These cells have the potential to accelerate research that will help both humans and companion animals in the future. https://lnkd.in/geDmKCHj

Changes in the world of veterinary cancer care are evolving at lightning speed and the word "cancer" should no longer imply dread or doom. Dr. Neal Mauldin - a veterinary oncologist - is kicking off our Pet Cancer Summit this week! He will explain how we should be thinking about cancer and inform us about changes in therapy that are helping us achieve better outcomes for dogs and cats with cancer. Join us! https://lnkd.in/gfmj7jjx #veterinarymedicine #veterinaryoncology

𝗚𝗿𝗼𝘂𝗻𝗱𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 We are excited to announce Cassandra CÉRÉ’s first scientific paper, ‘Quantitative MRI for brain lesion diagnosis in dogs and cats: A comprehensive overview’, published in the Veterinary Radiology & Ultrasound journal. In her CIFRE thesis, Cassandra reviewed quantitative MRI techniques (papers) for diagnosing brain lesions in dogs and cats, offering a detailed look at the latest advances in veterinary imaging. This research paves the way for innovation, providing valuable insights to improve veterinary practices and meet the evolving needs of professionals in the field. 📖 Read the full paper (Open Access): https://lnkd.in/dHimtfQy #Publication #Scientific #Veterinary #HawkCell

Is there a connection between multiple sclerosis (MS) in humans, and necrotizing meningoencephalitis (NME) in pets?   During the American College of Veterinary Internal Medicine (ACVIM) forum, Dr. Rebecca Windsor, leader in veterinary neurology, explained how peripheral inflammation plays a significant role in MS, a disease which shares many similarities to NME in pugs. NME is a fatal, noninfectious, inflammatory brain disease.  Mesenchymal Stem Cells (MSCs) are showing promise for humans with MS, and findings appear to parallel the early results demonstrated in studies evaluating MSCs for pugs with an early form of NME. MSCs modulate the immune system to make it less inflammatory and promote tissue repair in the brain. This is one impactful example of the importance of One Health.   #VeterinaryMedicine #StemCellTherapy #MultipleSclerosis #InnovationInHealthcare #OneHealth